Panel Discussion | Novel Targets in Development for IgA Nephropathy: Where are the Current Late Phase Trials Heading?
Time: 11:00 am
day: Pre-Conference Seminar Day
Details:
- From complement to APRIL to ETA: what targets are currently in development and looking most promising?
- Exploring new treatment possibilities with combinational targeting
- Exploring the current thinking on IgA pathogenesis to direct priorities for future target development
